Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 15. November 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3110  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 62191  
   
Periodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.
J Oral Microbiol
Fan L, Hong G, Sun J, Zhou Y, Shi J.
PMID: 43032645 [PubMed]


Explainable artificial intelligence identifies circulating microRNA candidate biomarkers for liquid biopsy-based pancreatic cancer detection.
Front Artif Intell
Mandal S, Ansari MA, Chanu WP.
PMID: 43032186 [PubMed]


Ozone therapy in colorectal cancer.
Front Oncol
Li Y, Pu R, Yang S, Chen H, Zhang X.
PMID: 43032072 [PubMed]


Complement in cancer-associated fibroblasts: sources, regulation and context dependence.
Front Immunol
Lei K.
PMID: 43032046 [PubMed - indexed for MEDLINE]


Periostin within the tumor microenvironment: molecular insights and immunomodulatory roles in cancer.
Front Immunol
Zhao Y, Yu Y, Li S, Xu L, Chen W, Lv J.
PMID: 43032026 [PubMed - indexed for MEDLINE]


Food Environment, Food Access, and Disparities in Pancreatic Cancer Outcomes: A Narrative Review of Evidence Gaps and Future Directions.
Nutrients
Liu C, Burch C, Bandy V, Gibson A, Vudatha V, Freudenberger D, Lambdin J, Herremans K, Riner A, Fernandez L, Trevino J.
PMID: 43030263 [PubMed - indexed for MEDLINE]


DNA Repair Pathways as Determinants of PARP Inhibitor Resistance and Therapeutic Targets in Cancer.
Int J Mol Sci
Lavudi K, Renjith MS, Pithana Sai Venkata Vijay C, Kokkanti RR, Pandey P, Ponneganti S.
PMID: 43028061 [PubMed - indexed for MEDLINE]


Changing Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment.
Int J Mol Sci
Bertalmio N, Marino FAL, Brundu S, Rustichelli S, Giraudo E.
PMID: 43028035 [PubMed - indexed for MEDLINE]


Cancer Risk Linked to Ultra-Processed Foods: Epidemiological Findings, Potential Mechanisms, and Research Outlook.
Foods
Zhao M, Zhang X.
PMID: 43027519 [PubMed]


The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer.
Cancers (Basel)
Smith JP.
PMID: 43026872 [PubMed]


Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990-2023: Evidence from the Global Burden of Disease Study 2023.
Cancers (Basel)
Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, Zheng Y, Liu Y.
PMID: 43026856 [PubMed]


Treatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.
Cancers (Basel)
Turner KM, Gurewitz JB, Frakes JM, Denbo JW, Malafa MP, Hodul PJ, Kim DW, Sinnamon AJ.
PMID: 43026841 [PubMed]


Synergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer.
Cancers (Basel)
Ghosh AK, Jazieh KA, Xie H, Parish MA, Babiker HM, Bekaii-Saab TS, Goenka AH, Knutson KL, Pandey A, Fernandez-Zapico ME, Carr RM, George B.
PMID: 43026840 [PubMed]


Circulating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring.
Cancers (Basel)
Abue M, Asano N, Morikawa T, Masamune A, Nishizuka S, Yasuda J.
PMID: 43026792 [PubMed]


The Association Between Asthma and Pancreatic Cancer: A Systematic Review.
Cancers (Basel)
Darawsha B, Lavu H, Yeo CJ, Hanna N, Nevler A.
PMID: 43026779 [PubMed]


Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Pancreatic Neuroendocrine Neoplasms.
Cancers (Basel)
Jab.
PMID: 43026749 [PubMed]


A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.
HPB (Oxford)
Agritelley ES, Kanu EN, Button J, Bao M, Sannareddy DS, Fletcher AA, Skinner H, Molvin A, Rodgman M, Murray S, Chai J, Niedzwiecki D, DeVito NC, Blobe GC, Strickler JH, Hsu SD, Howard M, Abbruzzese JL, Martin AN, Zani S, Lidsky ME, Kim CY, Suhocki P, Cline B, Johnson D, Crosby EJ, Mettu NB, Mastria E, Allen PJ, Nussbaum DP.
PMID: 43026127 [PubMed - as supplied by publisher]


Impact of Clonal Hematopoiesis on Outcomes in Metastatic Pancreatic Ductal Adenocarcinoma: Analysis From the PASS-01 Trial.
JCO Precis Oncol
Sainamthip P, Somadasan M, Culnane L, Andrews E, Brais L, Andrews M, Jang GH, Zhang A, Wilson JM, Ramotar S, Dodd A, Perez KJ, Yu K, Laheru D, King DA, O'Kane GM, Gallinger S, Tuveson D, Jaffee EM, Knox JJ, Notta F, Aguirre AJ, Wolpin BM, Sperling AS, Singh H.
PMID: 43024846 [PubMed - indexed for MEDLINE]


Pathologic and Molecular Characterization of Branch Duct Intraductal Papillary Mucinous Neoplasm With Advanced Neoplasia Under-Recognized by Kyoto High-Risk Stigmata.
Pancreas
Maloof T, Chen W, Esnakula AK, Frankel WL, Culp S, Abdelbaki A, Hart PA, Machicado JD, Cruz-Monserrate Z, Shah ZK, Pawlik TM, Krishna SG.
PMID: 43024803 [PubMed - as supplied by publisher]


Tumor Treating Fields and Quality of Life Among Patients With Locally Advanced Pancreatic Adenocarcinoma: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
Macarulla T, Picozzi V, Chandana SR, Melichar B, Kasi A, Gang J, Gallego J, de la Fouchardière C, Bullock A, Chunyi H, Wyrwicz L, Osipov A, Dragovich T, Lee W, Feeney K, Philip PA, Ueno M, Van Cutsem E, Seufferlein T, Babiker H, PANOVA-3 study investigators.
PMID: 43024239 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 62191    Seite 1 von 3110  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1